'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer.

Higgins, Luke M; Lester-Coll, Nataniel H; Ades, Steven; Barry, Maura M; Borrazzo, Edward C; Ganguly, Eric K; Anker, Christopher J

Higgins, Luke M; Lester-Coll, Nataniel H; Ades, Steven; Barry, Maura M; Borrazzo, Edward C; Ganguly, Eric K; Anker, Christopher J.

Afiliação

Higgins LM; University of Vermont Larner College of Medicine, Burlington, VT, USA.
Lester-Coll NH; Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Ades S; University of Vermont Cancer Center, Burlington, VT, USA.
Barry MM; University of Vermont Cancer Center, Burlington, VT, USA.
Borrazzo EC; Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Ganguly EK; University of Vermont Cancer Center, Burlington, VT, USA.
Anker CJ; Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.

J Gastrointest Oncol ; 14(2): 480-493, 2023 Apr 29.

Article em En | MEDLINE | ID: mdl-37201058

Palavras-chave

Esophageal neoplasms; esophagectomy; neoadjuvant therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google